Treatment of a Mouse Model of ALS by In Vivo Base Editing

Colin K.W. Lim, Michael Gapinske, Alexandra K. Brooks, Wendy S. Woods, Jackson E. Powell, M. Alejandra Zeballos C., Jackson Winter, Pablo Perez-Pinera, Thomas Gaj

Research output: Contribution to journalArticlepeer-review


Lim et al. establish a trans-splicing system to deliver CRISPR base editors in vivo that enables treatment of a mouse model of ALS. They show that base editing can increase survival and slow the progression of disease.

Original languageEnglish (US)
Pages (from-to)1177-1189
Number of pages13
JournalMolecular Therapy
Issue number4
StatePublished - Apr 8 2020


  • AAV
  • ALS
  • base editor
  • CRISPR-Cas9
  • gene editing
  • gene therapy
  • neurodegeneration
  • SOD1
  • split intein

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Pharmacology
  • Drug Discovery


Dive into the research topics of 'Treatment of a Mouse Model of ALS by In Vivo Base Editing'. Together they form a unique fingerprint.

Cite this